Invention Grant
- Patent Title: Targeting microRNAs for the treatment of fibrosis
-
Application No.: US15380629Application Date: 2016-12-15
-
Publication No.: US09970007B2Publication Date: 2018-05-15
- Inventor: B. Nelson Chau
- Applicant: Regulus Therapeutics Inc.
- Applicant Address: US CA San Diego
- Assignee: Regulus Therapeutics Inc.
- Current Assignee: Regulus Therapeutics Inc.
- Current Assignee Address: US CA San Diego
- Agency: McNeill Baur PLLC
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C07H21/04 ; C12N15/113 ; A61K31/7125 ; A61K45/06
Abstract:
Provided herein are compositions and methods for the modulation of miR-214 for the treatment and/or prevention of fibrosis and fibroproliferative conditions.
Public/Granted literature
- US20170198289A1 TARGETING MICRORNAS FOR THE TREATMENT OF FIBROSIS Public/Granted day:2017-07-13
Information query
